Murine cytotoxic T lymphocytes specific for herpes simplex virus type 1 recognize the immediate early protein ICP4 but not ICP0
- PMID: 2172452
- DOI: 10.1099/0022-1317-71-10-2391
Murine cytotoxic T lymphocytes specific for herpes simplex virus type 1 recognize the immediate early protein ICP4 but not ICP0
Abstract
Vaccinia virus recombinants expressing the herpes simplex virus type 1 (HSV-1) genes encoding ICP0 or ICP4 were used to identify the precise target antigen(s) of murine anti-viral cytotoxic T lymphocytes (CTL) specific for the non-structural immediate early proteins. These studies revealed that HSV-1-specific CTL, restricted to class I major histocompatibility complex genes of the H-2k haplotype but not the H-2d or H-2b haplotypes, would lyse autologous cells expressing ICP4. HSV-1-specific CTL derived from various mice strains failed to lyse target cells expressing ICP0. Calculation of the frequencies of H-2k-restricted virus-specific CTL demonstrated that approximately a third of the total HSV-1-specific response was directed against ICP4. Immunization of mice with either recombinant vaccinia virus or transfected L cells expressing ICP4 induced HSV-1-specific lymphoproliferation and delayed hypersensitivity but CTLs were not induced. More importantly, such immunized animals were unable to resist or control a subsequent challenge with virulent HSV-1.
Similar articles
-
Herpes simplex virus type 1-specific cytotoxic T lymphocytes recognize immediate-early protein ICP27.J Virol. 1991 Jun;65(6):3185-91. doi: 10.1128/JVI.65.6.3185-3191.1991. J Virol. 1991. PMID: 1709698 Free PMC article.
-
Immunogenicity of herpes simplex virus type 1 mutants containing deletions in one or more alpha-genes: ICP4, ICP27, ICP22, and ICP0.Virology. 1999 Apr 10;256(2):258-69. doi: 10.1006/viro.1999.9653. Virology. 1999. PMID: 10191191
-
The proportion of herpes simplex virus-specific cytotoxic T lymphocytes (Tc) that recognize glycoprotein C varies between individual mice and is dependent on the form of immunization.Viral Immunol. 1993 Spring;6(1):21-33. doi: 10.1089/vim.1993.6.21. Viral Immunol. 1993. PMID: 8386515
-
Live vaccinia virus recombinants expressing herpes simplex virus genes.Rev Infect Dis. 1991 Nov-Dec;13 Suppl 11:S898-903. doi: 10.1093/clind/13.supplement_11.s898. Rev Infect Dis. 1991. PMID: 1664124 Review.
-
Adenovirus vectors as potential vaccines against herpes simplex virus.Rev Infect Dis. 1991 Nov-Dec;13 Suppl 11:S912-6. doi: 10.1093/clind/13.supplement_11.s912. Rev Infect Dis. 1991. PMID: 1664127 Review.
Cited by
-
Therapeutic immunization with a virion host shutoff-defective, replication-incompetent herpes simplex virus type 1 strain limits recurrent herpetic ocular infection.J Virol. 2002 Apr;76(8):3615-25. doi: 10.1128/jvi.76.8.3615-3625.2002. J Virol. 2002. PMID: 11907201 Free PMC article.
-
Recognition by and in vitro induction of cytotoxic T lymphocytes against predicted epitopes of the immediate-early protein ICP27 of herpes simplex virus.J Virol. 1993 Jan;67(1):613-6. doi: 10.1128/JVI.67.1.613-616.1993. J Virol. 1993. PMID: 7677961 Free PMC article.
-
Herpes simplex virus type 1-specific cytotoxic T lymphocytes recognize immediate-early protein ICP27.J Virol. 1991 Jun;65(6):3185-91. doi: 10.1128/JVI.65.6.3185-3191.1991. J Virol. 1991. PMID: 1709698 Free PMC article.
-
Immunization with the immediate-early tegument protein (open reading frame 62) of varicella-zoster virus protects guinea pigs against virus challenge.J Virol. 1993 Dec;67(12):7673-6. doi: 10.1128/JVI.67.12.7673-7676.1993. J Virol. 1993. PMID: 8230489 Free PMC article.
-
Replication-defective mutants of herpes simplex virus (HSV) induce cellular immunity and protect against lethal HSV infection.J Virol. 1992 Dec;66(12):7067-72. doi: 10.1128/JVI.66.12.7067-7072.1992. J Virol. 1992. PMID: 1331509 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources